Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
International Journal of Cancer
|
October 8, 2008
Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients
Paola Nisticò, Imerio Capone, Belinda Palermo, et al.
The Journal of Investigative Dermatology
|
September 14, 2016
Combining Type I Interferons and 5-Aza-2'-Deoxycitidine to Improve Anti-Tumor Response against Melanoma
Valeria Lucarini, Carla Buccione, Giovanna Ziccheddu, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 28, 2025
E. Coli cytotoxic necrotizing factor-1 promotes colorectal carcinogenesis by causing oxidative stress, DNA damage and intestinal permeability alteration
Michela Tozzi, Alessia Fiore, Sara Travaglione, et al.
Nature Immunology
|
August 24, 2022
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B
Martina Musella, Andrea Guarracino, Nicoletta Manduca, et al.
Nature Medicine
|
October 27, 2014
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
Antonella Sistigu, Takahiro Yamazaki, Erika Vacchelli, et al.
Oncoimmunology
|
May 6, 2015
Consensus guidelines for the detection of immunogenic cell death
Oliver Kepp, Laura Senovilla, Ilio Vitale, et al.
Oncotarget
|
December 25, 2014
Classification of current anticancer immunotherapies
Lorenzo Galluzzi, Erika Vacchelli, José-Manuel Bravo-San Pedro, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
International Journal of Cancer
|
October 8, 2008
Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients
Paola Nisticò, Imerio Capone, Belinda Palermo, et al.
The Journal of Investigative Dermatology
|
September 14, 2016
Combining Type I Interferons and 5-Aza-2'-Deoxycitidine to Improve Anti-Tumor Response against Melanoma
Valeria Lucarini, Carla Buccione, Giovanna Ziccheddu, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 28, 2025
E. Coli cytotoxic necrotizing factor-1 promotes colorectal carcinogenesis by causing oxidative stress, DNA damage and intestinal permeability alteration
Michela Tozzi, Alessia Fiore, Sara Travaglione, et al.
Nature Immunology
|
August 24, 2022
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B
Martina Musella, Andrea Guarracino, Nicoletta Manduca, et al.
Nature Medicine
|
October 27, 2014
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
Antonella Sistigu, Takahiro Yamazaki, Erika Vacchelli, et al.
Oncoimmunology
|
May 6, 2015
Consensus guidelines for the detection of immunogenic cell death
Oliver Kepp, Laura Senovilla, Ilio Vitale, et al.
Oncotarget
|
December 25, 2014
Classification of current anticancer immunotherapies
Lorenzo Galluzzi, Erika Vacchelli, José-Manuel Bravo-San Pedro, et al.
Page
of 4